Sernova

Sernova company information, Employees & Contact Information

Explore related pages

Related company profiles:

Sernova (TSX: SVA) (OTCQB: SEOVF) is a clinical-stage biotechnology company that is advancing its implantable Cell Pouch™ bio-hybrid organ which works to restore the body’s normal function so that people with type 1 diabetes (T1D) and other chronic diseases can focus on what matters most: living their lives.

Company Details

Employees
24
Founded
-
Address
700 Collip Circle, Suite 114,canada
Industry
Biotechnology
HQ
London, ON
Looking for a particular Sernova employee's phone or email?

Sernova Questions

News

Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang - Newsfile

Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang Newsfile

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med - GlobeNewswire

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med GlobeNewswire

Enhancing post-operative hypothyroidism treatment: rat thyroid autotransplantation into a pre-vascularized, retrievable cell pouch™ device - Frontiers

Enhancing post-operative hypothyroidism treatment: rat thyroid autotransplantation into a pre-vascularized, retrievable cell pouch™ device Frontiers

Breakthrough: New Drug Collaboration Shows 5X Better Results in Type 1 Diabetes Cure Trial - Stock Titan

Breakthrough: New Drug Collaboration Shows 5X Better Results in Type 1 Diabetes Cure Trial Stock Titan

Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans - GlobeNewswire

Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans GlobeNewswire

Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics - The Manila Times

Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics The Manila Times

Revolutionary Diabetes Treatment Achieves 5-Year Cell Survival in Clinical Trial - Stock Titan

Revolutionary Diabetes Treatment Achieves 5-Year Cell Survival in Clinical Trial Stock Titan

Sernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business Officer - Yahoo Finance

Sernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business Officer Yahoo Finance

Patients With T1D Achieve Insulin Independence Following Implantation of Cell Pouch System and Islet Transplant - CGTLive®

Patients With T1D Achieve Insulin Independence Following Implantation of Cell Pouch System and Islet Transplant CGTLive®

Sernova Update on Strategic Initiatives - GlobeNewswire

Sernova Update on Strategic Initiatives GlobeNewswire

Could This FDA-Cleared Thyroid Therapy End Lifetime Medication Dependence? - Stock Titan

Could This FDA-Cleared Thyroid Therapy End Lifetime Medication Dependence? Stock Titan

Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA - Yahoo Finance

Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA Yahoo Finance

Sernova Opens the Market - PR Newswire Canada

Sernova Opens the Market PR Newswire Canada

Vertex Doses First Patient in Phase 1/2 Trial of VX-264 in Type 1 Diabetes - CGTLive®

Vertex Doses First Patient in Phase 1/2 Trial of VX-264 in Type 1 Diabetes CGTLive®

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function - GlobeNewswire

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function GlobeNewswire

Sernova Corp. Announces Appointment of New Chief Executive Officer - GlobeNewswire

Sernova Corp. Announces Appointment of New Chief Executive Officer GlobeNewswire

Sernova Announces Positive Ongoing Interim Phase 1/2 - GlobeNewswire

Sernova Announces Positive Ongoing Interim Phase 1/2 GlobeNewswire

ROTH Capital Partners to Host Inaugural Healthcare - GlobeNewswire

ROTH Capital Partners to Host Inaugural Healthcare GlobeNewswire

Sernova Announces Agreement With CCRM to Produce Specialized Cells for the Treatment of Diabetes - GlobeNewswire

Sernova Announces Agreement With CCRM to Produce Specialized Cells for the Treatment of Diabetes GlobeNewswire

Top Sernova Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant